C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2004
12/29/2004	CA2525713A1 Benzofuran inhibitors of factor viia
12/29/2004	CA2524700A1 N-substituted 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators
12/29/2004	CA2523015A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists
12/28/2004	US6835845 Methine compound, material for organic luminescence element, and organic luminescence element using the same
12/28/2004	US6835838 Condensation of silicon compounds with aldehydes in the presence of titanium catalysts in solvents, then reducing and hydolyzing to form drugs used for prophylaxis of atherosclerosis or as enzyme inhibitors
12/28/2004	US6835832 Catalytic hydrogenation
12/28/2004	US6835744 3,3-substituted indoline derivatives
12/28/2004	US6835737 Quinoline inhibitors of cGMP phosphodiesterase
12/28/2004	US6835734 1,3-dioxolanes with antitussive activity
12/28/2004	US6835729 2-phenyl-1-[4(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
12/28/2004	US6835495 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
12/28/2004	US6835474 Red fluorescent dyes having high fluorescent strength and high color purity; high luminance; high efficacy by low voltage-driving; stability; durability; color conversion filter, pulp dyeing; photographic dye; sensitizers
12/28/2004	CA2281426C Substituted indole compounds as anti-inflammatory and analgesic agents
12/28/2004	CA2226039C Pyridylfuran and pyridylthiophene compounds
12/28/2004	CA2105923C 7-isoindolinyl-quinolone derivatives and 7-isoindolinyl-naphthyridone derivatives
12/23/2004	WO2004111044A1 Tricyclic compounds useful for the treatment of inflammatory and allergic disorders:process for their preparation
12/23/2004	WO2004111043A1 Zwitterionic non-linear optophores and devices incorporating same
12/23/2004	WO2004111042A1 N-heterocyclyl phenyl-substituted cyclic ketoenols
12/23/2004	WO2004111040A1 Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists
12/23/2004	WO2004111014A1 Pyrimidine derivatives as modulators of atp-binding cassette transporters
12/23/2004	WO2004111013A1 Hepatitis c virus inhibitors
12/23/2004	WO2004111007A1 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase
12/23/2004	WO2004111000A2 Piperidyl derivatives and their use as tachykinin antagonists
12/23/2004	WO2004110993A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/23/2004	WO2004110989A1 N-hydroxy-7-(arylamino)heptanamide derivatives useful for treating hyper-proliferative disorders
12/23/2004	WO2004110986A1 Benzamide derivative or salt thereof
12/23/2004	WO2004110453A1 Pyrimidine derivatives as cannabinoid receptor ligands
12/23/2004	WO2004089908A3 3-azabicyclo[3.2.1]octane derivatives
12/23/2004	WO2004085409A3 Compounds and libraries of pyridines, pyrazines, imidazo[1,2-a]pyrazines and 1h-imidazo[4,5-b]pyrazin-2-ones and first and second medical uses thereof
12/23/2004	WO2004085392A8 Melatonin derivatives and their use for treating neurological dysfunctions
12/23/2004	WO2004078128A3 Substituted pyridine derivatives useful in the treatment of cancer and other disorders
12/23/2004	WO2004074270A3 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
12/23/2004	WO2004073629A3 Hetero substitued sodium channel blockers
12/23/2004	WO2004072025A3 Substituted n-arylheterocycles, method for production and use thereof as medicaments
12/23/2004	WO2004071447A3 Substituted azole derivatives as therapeutic agents
12/23/2004	WO2004071390A3 Piperazine-2-carboxamide derivatives
12/23/2004	WO2004055010A3 Cyclopropyl compounds as ccr5 antagonists
12/23/2004	WO2004040003A3 Nucleotide-binding protein-directed probes and methods of their synthesis and use
12/23/2004	WO2003095438A9 Substituted phenylacetamides and their use as glucokinase activators
12/23/2004	US20040260094 such as 8-amino-4-benzylamino-quinoline-3-carboxylic acid ethyl ester; for treatment of Alzheimer's disease, Huntington's disease, Parkinson's disease, AIDS, stroke, ischemia, traumatic brain injury, spinal cord injury or osteoarthritis
12/23/2004	US20040259931 An urea derivative containing amide, amine or substitued amine groups and pyrrolidine ring(s), useful for treating obesity, anxiety or depression
12/23/2004	US20040259928 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment
12/23/2004	US20040259921 EP4 receptor selective agonists in the treatment of osteoporosis
12/23/2004	US20040259914 chemokine receptor (CCR) inhibitors for treating allergic or inflammatory diseases such as asthma or rheumatoid arthritis, multiple sclerosis, inflammatory bowel diseases; 2-((p-fluorobenzyl)piperidinylmethyl)cyclohexylureas of given formula
12/23/2004	US20040259910 Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors
12/23/2004	US20040259904 for treating cancer; 4'-(6,7-dimethoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)-1,1'-biphenyl-4-yl 1,4'-bipiperidine-1'-carboxylate for example
12/23/2004	US20040259890 trans-3'-oxo-N-(trans-4-phenylcyclohexyl)-spiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-carboxamide e.g.; neuropeptide Y receptor antagonists for treatment of bulimia, obesity or diabetes for example
12/23/2004	US20040259887 Cannabinoid receptor ligands and uses thereof
12/23/2004	US20040259884 Antiproliferative agents; antitumor agents; using 1-(4,5-bis(4-chlorophenyl)-2-(2,4-dimethoxyphenyl)-4,5-imidazol-1-yl)-2-methylpropan-1-one
12/23/2004	US20040259876 Bicyclic compound, production and use thereof
12/23/2004	US20040259869 Cycloalkyl alkanoic acids as integrin receptor antagonists
12/23/2004	US20040259868 Serine protease inhibitors
12/23/2004	US20040259864 Substituted pyrimidinone derivatives as ligands of integrin receptors
12/23/2004	US20040259859 Therapy for diseases caused by opioid receptors; irratible bowel disorders; drug abuse; antidepressants; anxiolytic agents; schizophrenia; eating disorders
12/23/2004	US20040259858 such as 3-(2-methyl-4-pyrrolidin-1-yl-quinolin-7-yl-methoxy)-benzonitrile; neuropeptide y receptor antagonists; for treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity
12/23/2004	US20040259843 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents
12/23/2004	US20040255397 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratimous fibers
12/23/2004	DE102004023605A1 New (pyrazol-4-yl)-(2,3-dihydro-benzofuran-4-yl or -benzothiophen-4-yl)-methanone derivatives, useful as pre- or post-emergence, total or selective herbicides or plant growth inhibitors
12/23/2004	CA2529068A1 Pyrimidine derivatives as cannabinoid receptor ligands
12/23/2004	CA2528888A1 N-heterocyclylphenyl-substituted cyclic ketoenols
12/23/2004	CA2528652A1 Nk1 antagonist
12/23/2004	CA2528644A1 Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams
12/23/2004	CA2527851A1 Hepatitis c virus inhibitors
12/23/2004	CA2526518A1 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase
12/23/2004	CA2526387A1 Benzamide derivative or salt thereof
12/22/2004	EP1489078A1 Benzofuran derivative
12/22/2004	EP1489077A1 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
12/22/2004	EP1488792A2 Quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
12/22/2004	EP1487978A2 An improved method for synthesising templated molecules
12/22/2004	EP1487851A2 A building block capable of functional entity transfer to nucleophil
12/22/2004	EP1487850A2 A building block forming a c-c or a c-hetero atom bond upon reaction
12/22/2004	EP1487849A2 A building block capable of transferring a functional entity
12/22/2004	EP1487848A2 A building block forming a c=c double bond upon reaction
12/22/2004	EP1487824A1 Diamino-pyrimidines and their use as angiogenesis inhibitors
12/22/2004	EP1487823A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
12/22/2004	EP1487822A2 Pyrrole-2,5-dione derivatives and their use as gsk-3 inhibitors
12/22/2004	EP1487819A2 Azepane derivatives and their use as atk1 inhibitors
12/22/2004	EP1487817A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487813A1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
12/22/2004	EP1487812A1 Anomeric derivatives of monosaccharides
12/22/2004	EP1487807A2 New compounds
12/22/2004	EP1487804A2 Aminoindazole derivatives as protein-kinase inhibitors
12/22/2004	EP1487803A1 Indazoles substituted with an anti-cancerous activity
12/22/2004	EP1487801A1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo[d]azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders
12/22/2004	EP1487798A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
12/22/2004	EP1487794A1 Monocyclic aroylpyridinones as antiinflammatory agents
12/22/2004	EP1487437A1 Methods of treatment with selective ep4 receptor agonists
12/22/2004	EP1487435A1 Azetidine derivatives as ccr-3 receptor antagonists
12/22/2004	EP1440067B1 N-formyl derivatives of paroxetine
12/22/2004	EP1436266A4 Methods and compositions of novel triazine compounds
12/22/2004	EP1406894B1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity
12/22/2004	EP1366041A4 Preparation of n-methylparoxetine and related intermediate compounds
12/22/2004	EP1086076B1 Sulfonamide inhibitors of aspartyl protease
12/22/2004	CN1556703A 1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1 antagonistic activity
12/22/2004	CN1556702A Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/22/2004	CN1181069C Novel inhibitors of farnesyl-protein transferase
12/22/2004	CN1181067C Benzofurans
12/22/2004	CN1181059C Quinoline-4-base derivative I
12/21/2004	US6833458 Practical syntheses of chiral trans-3, 4-disubstituted piperidines and the intermediates
12/21/2004	US6833442 Complex and method for producing epoxides by using the complex

1 ... 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 ... 694